The Influence of Matrix Stiffness on Extracellular Matrix Protein Expression in 3D Encapsulated Mammary Fibroblasts by Woods, Kathryn
Philadelphia College of Osteopathic Medicine
DigitalCommons@PCOM
PCOM Biomedical Studies Student Scholarship Student Dissertations, Theses and Papers
2015
The Influence of Matrix Stiffness on Extracellular
Matrix Protein Expression in 3D Encapsulated
Mammary Fibroblasts
Kathryn Woods
Philadelphia College of Osteopathic Medicine, kathrynwo@pcom.edu
Follow this and additional works at: http://digitalcommons.pcom.edu/biomed
Part of the Cancer Biology Commons, and the Neoplasms Commons
This Thesis is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been
accepted for inclusion in PCOM Biomedical Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For more
information, please contact library@pcom.edu.
Recommended Citation
Woods, Kathryn, "The Influence of Matrix Stiffness on Extracellular Matrix Protein Expression in 3D Encapsulated Mammary
Fibroblasts" (2015). PCOM Biomedical Studies Student Scholarship. Paper 95.
1  
Georgia Campus - Philadelphia College of Osteopathic Medicine 
The Biomedical Sciences Program 
Biomedical Sciences Department 
 
The Influence of Matrix Stiffness on Extracellular Matrix Protein Expression 
in 3D Encapsulated Mammary Fibroblasts 
 
A Thesis by Kathryn Woods 
Advisor: Abigail Hielscher, Ph.D. 
 
Submitted in Partial Fulfillment of the Requirement for the Degree of Master of 
Science in Biomedical Sciences June 2015 
 
 
 
 
 
 
 
 
 
 
 
PCOM Biomedical Sciences Degree Program 
Signatory Page for Master’s Thesis 
We approve the thesis of Kathryn Woods. 
 
                             
Abigail Hielscher, PhD                                                                             Date of Signature 
Assistant Professor of Anatomy  
Thesis Advisor 
 
 
Richard White, PhD       Date of Signature 
Professor of Neuroscience Pharmacology & Physiology 
 
 
Adwoa D. Aduonum, PhD     Date of Signature 
Associate Professor of Neuroscience & Physiology 
 
             
Brian Matayoshi, PhD      Date of Signature 
Associate Director, Biomedical Science  
Graduate Program 
Professor of Physiology 
2  
Abstract 
A disease that transcends all races is breast cancer, the second leading cause of death 
among women with cancer. One factor, which participates in breast tumor progression, is 
the extracellular matrix (ECM), an acellular, protein-rich entity, which drives several cell, 
processes shown to promote tumorigenesis. Specifically, abnormal expression patterns 
and cross-linking of matrix fibers induces a more dense tissue structure, which has been 
reported to drive breast cancer progression. Alterations in ECM expression and 
crosslinking are in part due to carcinoma-associated fibroblasts (CAFs), activated 
fibroblasts which deposit copious ECM in the breast tumor environment. The goal of this 
study is to understand how ECM expression patterns change following culture of human 
mammary fibroblasts (HMFs) in mechanically tuned 3 dimensional gelatin hydrogels, a 
culture setup that better mimics the natural breast environment. Since matrix stiffness has 
been reported to drive the myofibroblast phenotype, it is anticipated that altered ECM 
expression and deposition patterns will accompany HMF culture in mechanically stiff 
gelatin hydrogels. To alter the stiffness of the gel, microbial transglutaminase, which 
cross-links lysine and glutamine residues in the gelatin matrix, will be employed and 
rheology will be subsequently utilized to determine the bulk mechanical stiffness of 
cross-linked gels. Three gels with various stiffnesses including compliant, moderate, and 
stiff will be utilized for encapsulation of HMFs. Viability assays, such as the Live/Dead 
assay, will be utilized to monitor cell viability over the 7-day culture period. To assess 
whether matrix stiffness induces unique patterns of matrix expression, we will evaluate 
ECM protein expression using western blot for the following ECM proteins: tenascin-C, 
fibronectin, laminin and collagens I, IV. In addition, immunofluorescence will be utilized 
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to evaluate cellular deposition of ECM proteins in the gelatin hydrogel. Results from 
these assays will elucidate whether increasing matrix stiffness induces a more 
pronounced expression level of the aforementioned ECM proteins. Results from these 
studies may allow for future development of novel therapeutic agents targeted to the 
myofibroblast within the breast cancer microenvironment.  
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Introduction 
Breast Cancer  
Breast cancer is the second leading cause of death among women with cancer (DeSantis, 
2011). Approximately 232,670 new cases of invasive breast cancer (IBC) and 40,000 
breast cancer deaths are expected to occur among US women in 2014 (Siegel, 2014).  
IBC is a general type of breast cancer with a few subtypes detailing the specific location 
or way in which the cancer metastasizes outside of the breast tissue. Breast cancer 
commonly arises from abnormal cells, which proliferate within the duct, and is referred 
to as ductal carcinoma in-situ (DCIS). The difference between IBC and DCIS is that 
DCIS has not spread from the ducts into the surrounding breast tissue. It progresses from 
DCIS to invasive and metastatic cancer once the cancer cells breach the basement 
membrane and intravasate into the blood and lymph vessels (Kalluri, 2006). While many 
researchers have spent a great deal of time focusing on the cancer cells, recent efforts 
have focused on the role of the microenvironment in breast tumor progression. The 
microenvironment is composed of extracellular matrix (ECM), fibroblasts, blood, lymph 
vessels, nerves, and inflammatory cells which are collectively referred to as the stroma 
(Kalluri, 2006). One of the major cell structures that make up the connective tissue 
stroma is fibroblasts. They are non-vascular, non-epithelial, and non-inflammatory cells 
that are found throughout the connective tissue of the breast (Mangia, 2011). This stroma 
supports breast homeostasis and helps maintain its structure. When aberrant, the stroma 
actively participates in breast tumor formation and progression.  
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Myofibroblasts and Carcinoma-Associated Fibroblasts  
One of the major differences observed in the breast tumor microenvironment is the 
change to the stroma. In the absence of malignancy, the breast tissue contains a small 
number of fibroblasts and a physiological ECM; whereas, in breast cancer, the stroma 
becomes reactive (Rønnov-Jessen, 2009). The reactive stroma of breast cancers is usually 
characterized by a significant loss of myoepithelial cells and basement membrane, in 
addition to increased number of fibroblasts and myofibroblasts, which deposit a copious 
ECM matrix, as well as an influx of infiltrating immune cells (Kalluri, 2006; Rønnov-
Jessen, 2009). Myofibroblasts are activated fibroblasts characterized by the presence of 
alpha-smooth muscle actin (α-SMA), which is a component of the actin cytoskeleton, 
which increases the contractile ability of fibroblasts (Hinz, 2001; Yamashita, 2012). With 
regard to tissue homeostasis, the myofibroblast participates in wound healing, where it 
promotes remodeling of the connective tissue following injury (Yamashita, 2012). In 
cancers, myofibroblasts are referred to as carcinoma-associated fibroblasts (CAFs).  
CAFs are principally characterized by the expression of α-SMA and vimentin (a protein 
expressed in invasive cancers, related to high tumor invasion and chemoresistance) and 
the presence of actin stress fibers (Rønnov-Jessen, 1996; Tsukada, 1987; Gabbiani, 2003; 
Kalluri, 2006). CAFs promote breast cancer progression by influencing biological 
processes such as, cell-ECM adhesion, migration and invasion, and epithelial-
mesenchymal transition (EMT) (Yu, 2014). For example, Yu et al (2014), cultured 
several breast cancer cell lines with CAFs or their conditioned media, reporting that these 
cell lines showed a more aggressive phenotype due to TGF-β1 signaling from the CAFs 
(Yu, 2014). Furthermore, the CAFs in this study were shown to induce tumorigenesis 
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from normal epithelial cells, by inducing EMT (Yu, 2014), a phenomenon that allows 
cancer cells to initiate the metastatic cascade.   
 
 
 
ECM Proteins and Breast Cancer Progression 
The ECM is comprised of several proteoglycans and proteins and is thus a component of 
the non-cellular niche that actively sustains the morphology of tissues within organs (Lu, 
2012).  Under homeostatic conditions, the ECM participates in embryological 
development and wound healing (Lu, 2012). A couple important considerations of ECM 
biology is (1.) its biomechanical properties, which allows a cell to sense external forces 
generated by the ECM (Paszek et al., 2005; Lopez et al., 2008; Gehler et al., 2009), and 
(2.) its overall protein constituents contribute to disease (McBeath et al., 2004; Reilly and 
Engler, 2010). In breast cancer, for example, ECM proteins are aberrantly expressed in 
the matrix, contributing to increased tissue rigidity (Paszek et al., 2005), vascular 
morphogenesis (Hielscher et al 2012), and tumor invasion (Provenzano et al 2006, 2008).  
ECM proteins, which are abnormally expressed in the breast tumor microenvironment or 
have been shown to participate in breast tumor progression, include tenascin-C 
(Oskarsson et al, 2011; Hancox et al, 2009), fibronectin (Barkan et al, 2008; Williams et 
al 2008), laminin (Kim et al, 2012) and collagens I (Provenzano et al, 2006, 2008) and 
collagen IV (Nakano et al, 1999). 
Fibronectin has been shown to be one of the components driving myofibroblast 
differentiation from normal fibroblasts (Hinz, 2007).   It is also involved with cell-cell 
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and cell-matrix adhesions, cell migration, morphogenesis, differentiation and oncogene 
transformation (Gould, 1990). Similar to fibronectin, tenascin-C is a glycoprotein, which 
influences cellular adhesion, migration, morphogenesis and oncogenic alterations (Gould, 
1990; Ioachim, 2002). Laminin and collagen-IV are found within the basement 
membrane of the ECM (Ioachim, 2002). Laminin is reported to regulate cell migration 
and adhesion and participates in tumor invasion (Nielsen, 1984; Koochekpour, 1995; 
Ioachim, 2002). Collagen-IV on the other hand, has been reported to control mammary 
cell proliferation along with cell adhesion and migration (Kim, 1994; Ioachim, 2002).  
 
The hardening of tissue or ‘lump’ in the breast is one of the initial physical signs 
of malignancy. This dense tissue is comprised of increased ECM protein expression and 
remodeling in the form of matrix cross-linking (Butcher, 2009 and Sinkus, 2000). The 
increased stiffness of the ECM has been shown to promote tumor cell growth, survival, 
and migration (Lo, 2000). Most importantly, matrix stiffness has been shown to facilitate 
an activated fibroblast phenotype (Peyton et al, 2006, 2008). For example, Peyton et al, 
(2006) cultured smooth muscle cells atop mechanically tuned poly(ethylene) glycol 
(PEG) hydrogels functionalized with cell adhesive binding sites. Increased matrix 
stiffness combined with different cell adhesive sites promoted cell spreading, 
proliferation and focal adhesions and F-actin fiber formation, properties, which are 
indicative of an activated phenotype (Peyton, 2006). Further work by Peyton et al, (2008) 
have implicated the impact of ECM mechanics in 3D for cancer progression. 
Consequently, it has become commonly accepted that matrix stiffness is a feature of the 
tumor microenvironment and therefore participates in cancer progression. Thus, cancer 
progression occurs due to the cell’s tractional forces, which are balanced against the 
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ECM matrix rigidity allowing cells to migrate and move along the matrix that is able to 
resist the force (Peyton, 2008).  Overall, investigating the role of matrix stiffness on cell 
responses is an important  concept for understanding the role of substrate compliance on 
tumor progression. In order to investigate the impact of matrix stiffness on cell behavior, 
a biologically relevant culture setup is necessary.  
Three Dimensional Culture 
In order to better recapitulate cellular activities in vitro, it is important to culture cells in  
a substrate that mimics their in-vivo environment. Science has advanced over the years 
and has provided the ability to understand these concepts using a natural model of the 
cellular environment within cell culture, via two-dimensional (2D) and three-dimensional 
(3D) substrates. 2D cell culture is based on the growth of single cell populations on a flat 
surface substrate, such as tissue culture polystyrene. However, there are several 
limitations to the 2D culture substrate (Engler, 2007; Chen, 1997; Singhvi, 1994).  Some 
of these restraints include the confinement of cells to a planar environment that 
suppresses more complex morphologies (Tibbit, 2009). Also, cells grown on this 
platform are evidenced to experience minimal resistance to migration from lack of 
surrounding ECM (Tibbit, 2009). As a result, it is essential for cells to be cultured in an 
environment which better represents normal cell activities, such as cell-cell and cell-ECM 
interactions, cell signaling and growth, responses to exogenous factors, and cancer 
metastasis and tissue organization (Tibbit, 2009). To overcome the limitations of 2D 
culture, cell growth in 3D environments has been increasingly used (Tibbit, 2009).  
Hydrogels (used for 3D cellular culture) are a network of polymer chains 
principally made up of water, giving the hydrogel a natural tissue-like state useful for cell 
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culture (Nguyen and West, 2002). Specifically, gelatin hydrogels are desirable for a 
number of reasons. For example, gelatin is the denatured product of collagen, a 
ubiquitous protein in the breast microenvironment (Sung, 2014), making it a relevant 
scaffold for use to mimic the breast tumor microenvironment. Gelatin is also a desirable 
substrate since it is non-immunogenic, easy to use and can be mechanically modified 
using enzymatic approaches (Nimni, 1988). 
Transglutaminase 
The use of a cross-linking agent to tune the mechanical stiffness of hydrogels has become 
necessary and relevant to cell and tissue culture in biomedical research. Although a 
number of methods including UV light, glutaraldehyde and formaldehyde may be used to 
cross-link hydrogels, these agents are toxic to cells (Chen, 2005). As such, enzymatic 
methods have been adapted to induce cross-linking of hydrogels while minimizing 
toxicity to cells (Chen, 2005). One enzymatic approach is microbial transglutaminase 
(mTg) derived from streptoverticillium morabenese. Used widely in the food industry, 
mTg catalyzes protein polymerization by forming intermolecular and intramolecular 
lysine-glutamine cross-links in gelatin and collagen gels (Chobert, 1996). The mechanism 
of action for mTg is to catalyze an acyl-transfer reaction; y-carboxamide groups of 
peptide-bound glutamine residues act as the acyl donor, and E-amino groups of lysine 
residues act as the acyl acceptor to perform the protein polymerization bond (Folk, 1980). 
Aside from its cross-linking activities, other desirable properties of mTg include its wide 
range of pH stability, the range for controlled expression at different temperatures, and 
the cross-linking effect on tensile strength seen in the gels (Chen, 2005). Chen et al 
(2005) showed that following encapsulation of fibroblasts in mTg cross-linked gels, the 
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gels supported growth and viability of the cells  (Chen, 2005).  Additionally, studies by 
Yung et. Al (2007) exhibited the compliance of mTg cross-linked gelatin as a tissue-
engineering scaffold for the growth and encapsulation of HEK 293 human embryonic 
kidney cells. Overall, these studies demonstrate the utility of mTg cross-linked gels as 
suitable substrates for growth of cells.  
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Hypothesis 
HMFs cultured in a stiff gel as opposed to a compliant gel will exhibit a greater  
expression of ECM proteins. 
Specific Aims  
Specific Aim 1: Evaluate the effect of matrix rigidity on HMF cell viability. 
HMFs will be encapsulated in compliant, moderate and stiff gelatin hydrogels. In this 
analysis, 35,000 HMFs will be co-mixed with 7.5% gelatin containing 20 (compliant), 30 
(moderate), or 100 (stiff) µg/ml mTgase. The measured stiffness of the varying mTgase 
concentrations are as follows: compliant, ~300 Pascals; moderate ~1,300 Pascals; 
stiff/rigid ~2,000 Pascals. HMFs encapsulated in mTgase cross-linked gelatin will be 
incubated at 37oC for 30 minutes to facilitate cross-linking and with then be overlaid with 
1ml of complete media.  The cell morphology and viability are monitored via the 
Live/Dead assay over a 7-day culture period, and the proportion of live versus dead cells 
will be quantified using Image J. 
Specific Aim 2: Evaluate the effect of matrix rigidity on ECM protein expression. 
Expression of several ECM proteins including fibronectin (Sereini, 1998; Tomasek, 
2002) , collagens I (Binai, 2012; Hinz, 2007) and IV (Minz, 2010), tenascin-C (El-Karef, 
2007), and laminin (Marangon, 2014) are associated with the myofibroblast phenotype 
and/or breast cancer progression. Western blot will be utilized to quantify the expression 
of these proteins in both the conditioned media and in HMFs encapsulated in compliant, 
moderate and stiff gels at days 1,3,5 and 7. The cells will be isolated for Western blot. 
First, the gels will be digested with trypLe, then the remnants will be spun down to obtain 
the cell pellets. The cells will be incubated in a cell lysis buffer containing a protease 
17  
inhibitor cocktail. From here, total protein will be quantified using Bradford, then run on 
an SDS Page gel. Changes in protein expression will be observed using a LI-COR 
Odyssey imager. 
 
Specific Aim 3: Evaluate the effect of matrix rigidity on ECM protein deposition in 3D. 
Extracellular deposition of aforementioned ECM proteins will be evaluated using a Zeiss-
LSM510 confocal microscope. This analysis will elucidate whether HMFs in stiff gels 
deposit greater quantities of matrix proteins in the gel, an observation, which would link 
matrix stiffness with ECM deposition in 3D.  Gel preparation for imaging will be based 
off methods reported by Wozniak et al, 2003. Briefly, gels will be cut into 5 equal 
fragments and will be fixed in 4% paraformaldehyde overnight. Gels will be 
permeabilized using triton-X prior to staining with primary antibodies followed by 
staining with fluorescent secondary antibodies. Gel fragments will be mounted using 
Prolong Anti-Fade Mounting Medium and will be imaged the next day at days 1,3, 5 and 
7. Results from this work may be utilized in future analyses to evaluate the organization 
of ECM proteins in the 3D matrix.   
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Methods 
Microbial Transglutaminase Isolation 
A mTg solution was prepared using 2.5g crude mTg in 50mL Buffer A (20mM phosphate 
buffer & 2mM EDTA buffer, pH 6.0) to make a 5% solution. mTg was isolated using 
column chromatography. Prior to separation, 2.5ml of Sepharose FF beads were given 5 
minutes to settle out of solution.  The beads were then washed in 5 column volumes 
(Column Vol = 2.5mL) of Buffer A. Then they were mixed with the mTg solution and 
left overnight for incubation at 4oC. Following overnight incubation, the protein solution 
and bead mixture were loaded on a column, and washed with 4 column volumes of 
Buffer A. Then 3-5mL of Buffer B (NaCl in 20mM phosphate buffer and 2mM EDTA 
buffer, at pH 6.0) were added to the bead mixture. Fractions were eluted using varying 
concentrations of NaCl (0mM, 200mM, 400mM, 600mM, 800mM, and 1000 mM NaCl). 
After addition of Buffer B, the fraction eluant was separated into 1-5mL aliquots. Protein 
was purified from the NaCl using 10kDa ultracentifugal spin columns.  Concentrations of 
protein were determined using the DC assay. This is a method for evaluating the 
concentration of an unknown protein from a given a set of measured known protein 
concentrations. Absorbance values were obtained at a wavelength of 750nm using a 
microplate reader.  As a purity assurance method, a coomassie stain was run from 
purified protein on a 4-20% SDS PAGE gel.  
Cell Culture 
Human mammary fibroblasts (HMFs), an immortalized fibroblast cell line, was obtained 
from Dr. Parmjit Jat of the University College London. HMF cells were cultured in 
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DMEM (Life Technologies, Grand Island, NY) supplemented with 10% vol/vol heat 
inactivated FBS (Life Technologist). Media was replaced every 2-3 days and cells were 
passaged after reaching 80-90% confluence using 0.25% trypsin EDTA (Sigma, 
Allentown, PA). HMFs were maintained at 37oC in a humidified atmosphere containing 
5% CO2. 
mTG Treatment of 2D HMFs 
To determine whether mTG was toxic to HMFs, HMFs were treated with several 
concentrations of mTg, ranging from 6.3µg/mL to 500µg/mL. Prior to administering 
mTg, HMFs were plated in a 24 well plate and allowed to incubate overnight prior. The 
next day, the cells were treated in triplicate with various concentrations of mTg and were 
left to incubate overnight. HMF viability was measured using the Almar Blue reagent.  
Thermal Stability of mTG Hydrogels 
To evaluate the thermal stability of mTg cross-linked gelatin, gelatin was cross-linked 
with 6.3µg/mL and 500µg/mL mTg at 370C, then 1mL of 1X PBS was added to each gel.  
Prior to addition of PBS, the gels were weighed to obtain the initial weight, then 
incubated in 1mL of PBS at 37oC for one hour where weight was measured at each hour 
up to five hours total. For each weight measurement, PBS was carefully removed from 
the gels and then added back to the gels for continued incubation.  
Rheology of mTg Hydrogels 
Rheology was used to measure the bulk mechanical stiffness of the gel. Gelatin hydrogels 
were cross-linked with 15µg/mL, 20µg/mL, 30µg/mL, 60µg/mL, 75µg/mL, and 
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100µg/mL mTG and incubated at 370C for 2 hours to overnight in 1X PBS. These 
experiments were performed in collaboration with Kyung Park, Ph.D. and Sharon 
Gerecht, Ph.D. (Johns Hopkins University, Baltimore, MD).  
3D HMF Encapsulation 
In order to culture HMFs in gelatin hydrogels, HMFs were trypsinized as described above 
and 35,000 viable HMFs were encapsulated in 7.5% (3.75g in 50mL solution) gelatin 
cross-linked with varying concentrations of mTg (20, 30, and 60µg).  Cell viability was 
determined using an automated cell counter (Life Technologies). Gelatin was prepared 
using 1X PBS and sterilized using a steriflip (50ml sterile centrifuge tube top unit with 
pore size 0.22 µm).  Prior to HMF encapsulation, the sterile gelatin was pre-warmed for 
2-3 hours at 37.4oC in a water bath. To encapsulate HMFs in gelatin gels, 35,000 viable 
HMFs cells were resuspended in 20µL of serum-free media (DMEM). To this, 250µL of 
gelatin containing 20, 30, and 60µg of mTg was added to the cells and the gel 
encapsulated cell suspension was added to each of 4-10 wells of a 24-well plate. After 
plating, a gelation time of 30-45 minutes in a 37oC incubator was given to enable 
crosslinking. Upon polymerization, 1 mL of complete media was added to each gel. The 
gels were maintained at 37oC in a humidified atmosphere containing 5% CO2 for varying 
time points over a 7-day incubation period. 
Viability Assays 
The Live/Dead viability assay was used to quantify the amount of viable HMFs found 
within the various mTg cross-linked hydrogels. Viable HMFs in 20 and 30µg mTg gels 
were evaluated at days 1, 3, 5, and 7 post-encapsulation. Calcein AM (Life Technologies) 
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and ethidium bromide (Life Technologies) were used at a concentration of 1µM each. 
Both reagents were mixed with 5ml of sterile 1X PBS and added to cell-encapsulated gels 
at a volume of 500µL.   The gels were incubated in the dark at room temperature for 45 
minutes prior to imaging. The EVOS microscope (Life Technologies) was used for 
imaging live and dead cells.  A 10x objective was used to capture images in the GFP 
(live), RFP (dead), and phase channels. Three sets of images were taken per well at three 
non-overlapping locations. Images were analyzed using ImageJ (NIH) software, which 
enabled quantification of live and dead cells. Here, each image was converted to a binary 
image produce a black/white image that showed white cells on a black  background. 
After this viable and nonviable were manually counted to notate the number of live cells 
compared to dead cells. 
Collagenase Assay 
Collagenase (Sigma) was used to liberate HMFs from gelatin hydrogels. At days 1, 3, 5, 
or 7 of culture, the gelatin hydrogels were washed 3x each with 1X sterile PBS and 
incubated for 3 hours in 250µl of a 0.5mg/mL concentration of collagenase suspended in 
DMEM media containing 50µL of a 100x protease inhibitor cocktail solution (Sigma). 
Following incubation the contents were centrifuged at 4500 RPM for 10 minutes at 250C. 
The supernatant was decanted and the cell pellet was incubated in 500µL of ice cold 
RIPA Buffer with 5µL of a 100x protease inhibitor cocktail for 10 minutes. RIPA Buffer 
contains 150mM NaCl, 1.0% Triton X, 0.5% Sodium Deoxycholate (SDC), 0.1% SDS, 
and 50mM Tris pH 8.0. The lysed cell contents were microcentrifuged at 12,000 x g for 
10 minutes at 40C the lysate stored in -80°C. 
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DC Assay 
The DC Assay is used to measure the concentrations of unknown proteins based on a set 
of known bovine serum albumin (BSA) concentration values. Several concentrations of 
the BSA stock solution were prepared for the known protein concentration solutions 
(0mg/mL, 0.1mg/mL, 0.25mg/mL, 0.5mg/mL, 1.0mg/mL, 2.0mg/mL, 4.0mg/mL, 
6.0mg/mL, 8.0mg/mL, and 10mg/mL). Each known and unknown concentration was 
added to a 96-well plate, at 5uL per well, in triplicate. Following this, a volume of 25uL 
SA mix (1mL Reagent A + 20uL Reagent S) was added to well. Finally, 200uL of 
Reagent B (used to measure the amount of protein in the sample) was placed in each 
well. The plate was then incubated in the dark at room temperature for 15 minutes. The 
absorbances were analyzed at 750nM wavelength using a plate reader and the Gen5 
software. The absorbances were then plotted in GraphPad Prism software on a graph to 
attain the concentration vs. absorbance data. A linear regression was used to obtain the 
slope and equation of the line, which was y=mx + b. Where ‘y’ is the y-intercept, ‘m’ is 
the slope, ‘x’ is the concentration, and ‘b’ is the absorbance. Each unknown absorbance 
concentration was calculated, given the absorbance based on the data from the DC Assay.  
This allowed for the unknown volume needed for each protein to be used for western 
blotting. 
Western Blot  
Western blot is used for protein separation based on differences in the weight of proteins 
within a sample. Conditioned media from HMF encapsulated hydrogels was collected at 
days 1, 3, 5 and 7 from 20µg, 30µg, and 60µg mTg cross-linked gels. Protein lysate from 
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HMF encapsulated hydrogels was collected at days 1, 3, 5 and 7 from 20µg and 30µg 
mTg cross-linked gels. For collection of lysate from cell-encapsulated gels, the media 
was not changed during the incubation period. Protein lysate was collected from mTg 
gelatin hydrogels as previously described using collagenase.  For analyses of conditioned 
media, a volume of 30µL  (15µL conditioned media and 15µL laemelli buffer) was 
loaded per well into a 4-20% SDS PAGE gel (BioRad). As a control, complete media 
solution was used (15µl of complete media   and 15µl laemlli buffer). A solution of 5µl 
of LICOR molecular weight marker (LICOR, Lincoln, NE) in 25µL laemelli buffer was 
used for the ladder.  For analyses on protein lysate, 25µg of protein from HMFs isolated 
from 20µg and 30µg mTg gels was added to each well of a 4-20% SDS PAGE gel. Prior 
to loading, 14.75µL laemelli buffer and 0.75µL BME were added, with additional RIPA 
buffer to round out the volume of the sample  to 30µL total. Then, the protein sample was 
boiled at 95°C for 5 minutes, at which point each protein sample was loaded into the gel. 
For both the conditioned media and the protein lysate, the gel was run at 200V for 30 
minutes using a 1X SDS buffer solution (100mL 10X SDS buffer and 900mL DI water) 
for the running buffer. After this, the proteins were transferred to PVDF membranes 
(Biorad), pre-soaked in 100% ethanol, using a semi-dry blot module (TransBlot system). 
The transfer buffer that was used consisted of (10mL Tris Buffer, 30mL DI water, 10mL 
100% ethanol). Membranes were blocked for at least 3 hours, or overnight in Odyssey 
Blocking Buffer (LI-COR Biosciences, Lincoln, NE). Following this, there was an 
overnight incubation at 40C/constant shaking with the following antibodies: rabbit anti-
human collagen I (1:2,000), mouse anti-human collagen IV (1:250), rabbit anti-human 
laminin (1:400), mouse anti-human tenascin C (1: 150), rabbit anti-human fibronectin 
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(1:300), and rabbit anti-human GAPDH (1:1,000). Each of the antibodies were made up 
in Odyssey blocking buffer containing 0.1% tween 20. The next day the membranes were 
washed three times for fifteen minutes each at constant shaking in washing buffer (100 
mL 1X PBS, 1mL Tween-20, 900mL DI water). The blots were then incubated in 
secondary antibodies, [Goat anti-mouse/rabbit (1:10,000)] for one hour at room 
temperature. The secondary antibody was also made up in Odyssey blocking buffer, 
Tween-20, and SDS Buffer. After the secondary step, the membranes were washed three 
times for fifteen minutes each in washing buffer, and then imaged for presence of ECM 
proteins. The Odyssey CLx (LI-COR) was used for imaging the blots. The 700 channel 
was used to observe protein bands. 
Immunofluorescence Imaging 
Immunofluorescnece imaging was used to visualize the expression of certain ECM 
proteins, such as fibronectin and collagen I, in HMF encapsulated hydrogels. 3D 
hydrogels were removed from culture at respective experimental time points (day 1, 3, 5, 
and 7), and 3.7% formaldehyde fixative was added to each gel for an overnight 
incubation at 40C. Then, 0.2% triton-X was added for a 10-20 minute incubation at room 
temperature. Afterward, 1% donkey serum (blocking step) was added to the hydrogels for 
overnight incubation at 40C. The gels were then washed 3 times in 1X PBS for 5 minutes 
each. Next the gels were incubated at 40C overnight in a 1:50 dilution of mouse anti-
human fibronectin. The gels were then washed 3 times in 1X PBS for 5 minutes each. 
Next, the gels were incubated for one hourat room temperature with a   1:100 dilution of 
phalloidin-488 (Life Technologies) and a 1:100 dilution of anti-mouse Alexa Flour-568 
(Life Technologies). The secondary dilutions were made  in 1% donkey serum and 
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incubations were performed in the dark. The gels were washed again 3 times in 1X PBS 
for 5 minutes each. Afterward, the gels were incubated in a 1:1000 dilution of DAPI stain 
for 10 minutes in the dark. The wells were washed 3 times in 1X PBS for 5 minutes each. 
Following this, the wells were imaged at 10X and 40X magnification with GFP, RFP, 
DAPI, and phase channels, using the EVOS microscope. 
Statistical Analyses  
GraphPad Prism software was used for various statistical analyses. It was used to 
determine the concentration vs. absorption, when analyzing the data from the DC assays. 
This information ultimately was used to determine the concentrations of the unknown 
protein samples in the mTg eluant and in the protein lysate from HMFs encapsulated in 
mTg gels.  
GraphPad and Microsoft Excel were also used for determining significance from viability 
data. Here, a student’s t-test was performed by comparing the viability data (% live vs. % 
dead) for each experimental time point (days 1, 3, 5, and 7) in each gel condition. Anova 
was also used for multiple data set comparisons in the 2D mTG treatment. Data were 
reported using a bar graph and the standard deviation. The values of significance were 
*p≤ 0.05, **p≤0.01. 
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Results 
 
mTg Treatment of HMFs in 2D Culture 
 
Since mTg was necessary for cross-linking the 3D hydrogels, it was necessary to first 
determine whether the enzyme was toxic to HMFs. As a result, the concentration range 
for the maximum non-toxic amount of mTg that still maintained HMFs viability was 
determined. The HMFs were treated with various mTg concentrations (6.3 µg /mL – 500 
µg /mL) in a 2D tissue culture polystyrene plate.  HMF viability was measured using 
Almar blue. After treatment, the percent cell viability was measured, and it was 
determined that HMFs were viable at most mTg concentrations tested. It was found that 
the HMFs exhibited viabilities ranging from 80% to 105%, where 75-80% viability was 
considered acceptable (Figure 1). This data was used to help establish the concentration 
of mTg used for making compliant and stiff gels.  
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Figure 1: 2D HMFs Treated with mTg. HMFs were treated with varying concentrations of 
mTg, ranging from 6.3 µg /mL to 500 µg /mL in order to determine whether mTg was toxic to 
the cells. By adding varying mTg concentrations to HMFs grown in 2D polystyrene flasks, the 
viability was measured and the % viability was analyzed in the graph above. There was 
significant difference seen in comparing control to 100 µg /mL and 250 µg /mL, showing a 
greater compared decrease in viability than the other mTG concentrations. Viability was 
generally high for each of the tested concentrations with viability of 75-80% or above being 
acceptable. *p≤ 0.05, **p≤0.01. 
Figure 1 
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Thermal Stability 
After determining that mTg was relatively non-toxic to HMFs, the thermal stability of 
mTg cross-linked gels was measured. This was necessary as gel encapsulated HMFs were 
to be maintained in an incubator at 30oC. However, if the gels could not maintain a solid 
state at higher temperatures, the hydrogels would not be an optimal culture method for 
the HMFs. As 37oC is the storage temperature for cell cultures, the 370C incubator was an 
adequate method to determine the hydrogel’s stability. After crosslinking the gels 
(without HMFs) with 6.3µg/mL and 500µg/mL of mTg, 1mL of 1X PBS was added and 
the gels were placed in an incubator at 37oC where the weight of the gel was measured 
following removal of the PBS each hour up to 5 hours. The lowest and highest mTG 
concentrations were used in order to delineate their varied affect on viability. Incubating 
the gels in 1X PBS mimicked the culture environment of the hydrogels encapsulated with 
HMFs. Therefore, any loss of gel weight would signify decreased stability. The weight of 
the 6.3µg mTg gels somewhat increased in weight over a 5-hour period of time, 
indicating that this concentration of mTg yields a stable gel, which was found to swell 
over time (Figure 2). At 500µg mTg, the gels showed a slight decrease in weight 
throughout the 5 hour time frame (Figure 2).   
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Figure 2: Thermal Stability of mTg Gelatin Hydrogels. Gels were cross-linked with the 
lowest (6.3µg) and the highest (500µg) tested concentrations of mTg  in order to test the 
thermal stability of the gels. The gels were incubated at 370C in 1X PBS for 5 hours, where the 
gel weight was taken at each hour for analyses of stability. PBS was removed prior to 
weighing. Gels at the lowest mTg concentration swelled over time, while the gels in the highest 
mTg concentration had slight decrease in weight throughout the incubation period. Significant 
difference shown by  *p≤ 0.05, **p≤0.01. 
Figure 2 
30  
Gel Stiffness/Rheology 
 
In order to measure the bulk mechanical stiffness of mTg cross-linked gelatin hydrogels, 
rheology was used. This procedure allowed for the analysis of stress/strain of the gelatin 
hydrogels cross-linked with various mTg concentrations. ‘Stress/Strain’ is the degree of 
compression of biomaterial when a given force applied to it (Battista, 2005). Though 
colleagues at Johns Hopkins completed the process, the results were utilized for creating 
hydrogels designed to represent compliant and stiff substrates. The corresponding 
mechanical stiffness (shown in Pascals) for each of the mTg concentrations tested is 
listed in in Table 1. The data illustrate that with increasing mTg concentrations, higher 
mechanical stiffnesses were obtained. While 15µg of mTg yielded the most compliant 
gel, use of this concentration resulted in longer gelation times, which would likely result 
in death to the encapsulated HMFs. The highest concentrations tested (75 and 100µg) of 
mTg created environments that were exceedingly stiff and were not supportive to cell 
growth (data provided by Catlyn Thigpen, 2015). As previously mentioned, 60µg was 
also considered for the mTg concentration for mechanically-tuned stiffness. However, 
due to a lower proliferation shown in 60µg compared to 30µg, it was not included as 
being the stiffest hydrogel (from proliferation data from Catlyn Thigpen). Thus, 
concentrations of 20 and 30µg of mTg were utilized for generation of 3D hydrogels 
representing compliant and stiff scaffolds, respectively.  
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 Table 1: Gel Mechanical Stiffness in Response to mTg. Bulk mechanical 
stiffness of the hydrogels was taken by obtaining rheology measurements. 
Hydrogels were treated with various concentrations of mTg and were incubated 
at 370C overnight in 1X PBS to mimic conditions of cell culture. Pascals, 
(N/m2), was obtained from the stress/strain of the mTg gels.  
Table 1  
mTg G’ Pascals 
15µg 100 
20µg  300 
30µg 1200 
60µg 1300 
75µg 1800 
100µg 1900 
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Collagenase Digestion of mTg Hydrogels  
In order to complete several of the downstream studies on the effects of gel matrix 
stiffness on HMF ECM expression, the HMFs needed to be liberated from the hydrogels. 
Collagenase was used for this process with varying collagenase concentrations used to 
determine the optimum concentration and least amount of time needed to dissolve the gel. 
This was important, as enzyme left too long could damage or kill the HMFs in the gel. 
Using three different concentrations of collagenase (0.1mg/mL, 0.25mg/mL, and 
0.5mg/mL), it was determined that a 3-hour incubation in 0.5mg/mL of collagenase was 
the most effective concentration to digest the gels and liberate the HMFs encapsulated in 
30µg mTg gels (Figure 3). It was decided to test collagenase using the 30µg gel, because 
it was the most rigid gel, so the results would be most optimal for any gel type. To 
prevent loss of protein during the incubation process, 50µL of a protease inhibitor 
cocktail solution was added to the suspension. Each of the trials were completed in 
triplicate for validity of results.  
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Figure 3: Collagenase Digestion of mTg Gelatin Hydrogels. HMFs were 
encapsulated in 30ug hydrogels and collagenase added to breakdown the 
gels, liberating the cells. The collagenase enzyme concentrations used were 
0.1mg/mL, 0.25mg/mL, and 0.5mg/mL. It was observed that at 3 hours the 
0.5mg/mL concentration had more completely broken down the gels. Each 
trial was completed in triplicate. 
 
Figure 3 
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HMF Morphology in mTg Cross-Linked Hydrogels 
 
HMFs were encapsulated in mTg cross-linked gelatin hydrogels and observed over the 
culture period, in order to determine the effects of gel stiffness on HMF cell morphology. 
A schematic of the culture setup and downstream analyses are shown in Figure 4. In 
order to visually assess HMFs throughout the experimental period, the change in cell 
morphology was observed. Following 1 day of encapsulation in 20µg (compliant) and 
30µg (stiff) mTg cross-linked hydrogels, HMFs exhibit a rounded and spherical shape 
(Figure 5). As the HMFs began to adhere to the surrounding environment, they formed 
protrusions.  These protrusions were observed at days 3 and 5 of culture in the compliant 
and stiff gels (Figure 5). At day 7, HMFs in the compliant and stiff gels were more 
pronounced than at earlier time points. This is evidenced by a greater amount of cells 
seen throughout the wells for both compliant and stiff gels (Figure 5).   
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Figure 4: 3D Hydrogel HMF Culture System. HMFs were encapsulated in 7.5% gelatin hydrogels, cross-linked 
with 20µg (compliant) and 30µg (stiff) of mTg. This culture approach is necessary to assess how mechanical 
stiffness, achieved using different concentrations of mTg, affected the behavior of HMFs. This schematic details 
the way that HMFs were encapsulated in mTg gelatin hydrogels to create a 3D scaffold. This culture method 
served as the basis for all downstream experiments, such as viability, morphology, western blot, and 
immunofluorescence. 
Figure 4 
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Figure 5: HMF Morphology in mTg Gelatin Hydrogels. Changes in the morphology of 
HMFs encapsulated in gelatin cross-linked with 20µg mTG (compliant) and 30µg mTg 
(stiff) were observed over the 7-day culture period. At day 1 it is seen that the cells are 
rounded and have similar morphologies. Day 3 shows that the compliant gel has a few more 
cells present, but in both data sets compliant and stiff cells show some degree of cell 
spreading. HMFs in Day 5 show that cells have more protrusions but the morphologies are 
still similar between compliant and sti gels. There are major differences seen at day 7, 
where cells in the stiff gel are more numerous compared to the cells of the day 7 compliant 
gel. Images were taken at 10X magnification using the phase channel of the EVOS 
microscope.   
Figure 5 
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HMF Viability in mTg Cross-Linked Gelatin Hydrogels  
 
Another key component of optimizing the 3D culture system is to ensure that HMFs are 
viable within the compliant and stiff hydrogels throughout the designated culture period. 
It was important to assess the cells’ viability in order to later measure cell responses 
within the gel. The denoted period was selected to be 7 days, with the viability assays 
conducted at days 1, 3, 5, and 7. HMF viability was measured using the Live/Dead assay 
and imaged using the EVOS microscope with Calcein (live cells) shown via the GFP 
channel, and ethidium bromide (dead cells) observed via the RFP channel (Figure 6A). 
The HMFs were then analyzed using ImageJ software for quantifying the number of live 
and dead cells.  Manual counting of binary images from live and dead cells was 
performed to analyze viability (per day, in either compliant or stiff gels). The compliant 
gels ranged in viability as follows: Day 1 (25.8%-74.2%), Day 3 (20.4%-79.6%), Day 5 
(8.2%-91.8%), and Day 7 (13.7%-86.3%).  Comparably, the stiff gels percent viability 
ranged from, Day 1 (8%-92%), Day 3 (10.1%-88.9%), Day 5 (17.2%-82.8%), and Day 7 
(2.7%-97.3%). It was found overall that HMFs are viable throughout the culture period in 
compliant and stiff mTg cross-linked gels (Figure 6B).   
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Figure 6 
 
 
 
 
Figure 6: HMF Viability in mTg Gelatin Hydrogels.  (A) These images show representative results from 
the Live/Dead Assay. The GFP channel shows (green) live cells, stained with Calcein. The RFP channel 
shows (red) dead cells, stained with EtBr. The phase channel shows the cell morphology.     
Compliant 
Stiff 
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Figure 6: HMF Viability in mTg Gelatin Hydrogels. (B) This data shows that HMFs are viable when 
encapsulated in mTg gelatin hydrogels in both compliant and stiff mTg concentrations.   
B 
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ECM Protein Expression in Conditioned Media 
 
The initial method for measuring changes in the expression of ECM proteins was to 
evaluate ECM protein expression in conditioned media from gel encapsulated HMFs. 
First, protein in conditioned media from HMFs encapsulated in compliant and stiff 
hydrogels at days 1, 3, 5, or 7 was collected and separated using  2D SDS PAGE 
electrophoresis. Then the blots were analyzed for differences in the expression of 
collagen I, collagen IV, fibronectin, and laminin. Collagen I expression was observed in 
the compliant gels, but its expression decreased from Day 1 to Day 7 (Figure 7). 
However, collagen I in the stiff gels had very high expression with Day 3 being the most 
pronounced (Figure 7). Fibronectin had an overall low expression level for both gel 
conditions. For the compliant gels, there was some expression, with an overall increase 
from day 3 through 7, but the stiff gels showed barely any fibronectin (Figure 7). Though 
the intention was to test the conditioned media for presence of several ECM proteins, 
after observing little expression of collagen I and fibronectin, it was decided  to evaluate 
ECM expression in cell lysate as opposed to conditioned media.  
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Figure 7: ECM Protein Expression in Conditioned Media. Overall, conditioned media did not express a 
large amount of ECM proteins. Collagen I had the highest expression in compliant gels expression at day 1.In 
the stiff gels, collagen I expression was higher than that of compliant gels for all times points. Examining 
expression in the stiff gels, it was especially high at day 3. Fibronectin had minimal expression overall. Some 
fibronectin expression was detected in the compliant gels and barely any in the stiff gels. Ponceau S stain was 
completed as a loading control. The overall purpose of this test was as an initial indicator of ECM protein 
presence shown in the 3D encapsulated HMFs.    
Figure 7 
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DC Assay for Analyses of Protein Concentration 
 
The DC assay was used to ascertain the concentration of unknown proteins, given the 
concentration and absorbance of a set of known proteins, based upon varying BSA 
concentrations. The following data was used specifically to determine the protein 
concentration and resulting volume to be used for western blot analyses of HMFs 
encapsulated in 20µg and 30µg mTG gels (Figure 8). After obtaining the known 
concentration and absorbance values of the BSA standards, the unknown protein values 
were determined. This was done by calculating the concentration of each unknown 
protein, based on the given absorbance values from the known BSA controls.  
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Figure 8. DC Assay of HMF Protein Lysate from Compliant and Stiff Gels. These graphs of known BSA 
concentrations were obtained by plotting the absorbance readings of BSA known proteins. This data was used 
to determine the unknown protein concentrations of HMFs encapsulated in compliant and stiff gels. This 
information was used to further dictate the volume of  protein from HMFs in the tested gel conditions to be 
added to a  2D SDS PAGE Electrophoresis gel for analysis of ECM protein expression.    
Figure 8 
  
30ug DC Assay 20ug DC Assay 
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ECM Protein Expression in HMF Protein Lysate  
 
After testing the conditioned media from the compliant and stiff gels, there was not much 
ECM protein expression observed except for fibronectin and collagen I. To evaluate 
ECM protein expression in the cell lysate, the HMFs were liberated via the collagenase 
assay as described on page 23. Using 2D PAGE electrophoresis and Western blot, protein 
lysate from compliant and stiff gels at days 1, 3, 5, and 7 were analyzed for the presence 
of fibronectin, collagen I, collagen IV, laminin, and tenascin-C.  Within the compliant 
gel, the most highly expressed proteins were collagen I, collagen IV, and fibronectin.  In 
comparison to compliant gels, HMFs in stiff gels had a greater level of expression of 
collagen I between days 1 through 5, with a slight decrease at day 7 (Figure 9).  Collagen 
IV expression was greatest for HMFs in the compliant gel at day 1, and then for HMFs in 
the stiff gel at days 3, 5, and 7 (Figure 9). Fibronectin expression was greater for HMFs 
in the compliant gels at all times points tested with the exception of day 7 (Figure 9). 
Laminin was not detectable in HMFs encapsulated in both the compliant and stiff gels 
(Figure 10). Tenascin-C had very little expression in HMFs in both gels (Figure 9). 
GAPDH was the loading control for accuracy of measurements. 
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Figure 9: ECM Protein Expression in HMF Protein Lysate.  The bands shown detail the ECM protein 
expression of HMFs encapsulated in compliant and stiff gels. For compliant gels, fibronectin has the highest 
level of expression. For the stiff gels, collagen I and collagen IV have highest levels of expression. Tenascin-C 
was evidence at days 5 and 7 in the compliant gels and at day 1 in the stiff gels. Laminin was undetected in 
both gel conditions. GAPDH was used as the loading control. The images are representative of all data 
gathered. Each ECM protein test was repeated in triplicate.    
Figure 9  
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Immunofluorescence for ECM Protein Expression  
 
In an attempt to visualize the ECM proteins expressed and/or deposited within the 3D 
hydrogels, immunofluorescence imaging was employed. Based upon results of ECM 
protein expression observed from   3D encapsulated HMFs, fibronectin was selected for 
these analyses as it was highly expressed. To image these proteins, the entire gel was 
fixed and stained with rabbit anti-human fibronectin primary antibody, along with anti-
rabbit Alexa Fluor 546 secondary stain and phalloidin 488, which binds actin filaments. 
Then DAPI was used to stain the nuclei of the cells. The resulting fibronectin stain was 
inconclusive; however the phalloidin and DAPI stains were both highly visible. (Figure 
10)  As this technique did not work, the gel was sectioned down to a more manageable 
staining size. The gel fragments were stained with rabbit anti-human fibronectin primary 
antibody, along with anti-rabbit Alexa Flour 546 secondary stain and phalloidin 488.  
Results showed that the typical morphology of the HMFs was altered, an observation that 
may potentially be a result of disruptions in the integrity of the gel once it was pulled out 
of the well plate (Figure 10). Imaging of the gel fragments revealed a very faint presence 
of fibronectin staining, though phalloidin and DAPI were robustly shown (Figure 10). 
Last, the gel was plated into a smaller 96-well plate instead of a 24-well plate since the 
surface area needed for gel polymerization was decreased. However, no fibronectin 
staining was observed when imaging (Figure 10). Overall, the methods used for 
immunofluorescence staining of ECM proteins were not successful. In order to identify 
fibronectin as well as other ECM proteins, alternate techniques would need to be 
employed. 
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Figure 10. ECM Protein Expression in 3D HMFs. HMFs were analyzed using fluorescence microscopy for their 
expression of fibronectin.  These images illustrate: (A) staining in a full gel image. (B) staining in a  gel that was 
sectioned. (C) staining in a smaller gel surface area, from a 24-well to 96-well plate. Fibronectin was not detectable in any 
of the stained conditions.  The low amount of fibronectin staining is possibly due to lack of adequate methods for 
visualizing particles within the gel. Also, it is possible that the environment is changing therefore not allowing the ECM 
proteins to exhibit their true effects from the surrounding stiff environment.   
Figure 10 
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Discussion 
 
Stiffness in breast cancer is a key sign for the initiation of tumor progression. By 
understanding the effect of the extracellular matrix and fibroblasts, components of the 
tumor microenvironment, it is possible to gain a clearer sense of the effects these proteins 
and cells have on tissue stiffness and the production of a more tumor-like environment in 
the breast tissue. The purpose of this project was to determine the effect that stiffness has 
on fibroblast cells within a breast tumor-like environment. In order to mimic the tumor 
environment, a 3D cell culture system was created where hydrogels were mechanically 
tuned using mTg. The overall hypothesis that HMFs in stiff gels would exhibit enhanced 
ECM protein expression compared to HMFs in compliant gels was not completely shown 
throughout this work.  
There were several parameters to be optimized prior to completing the 
encapsulation of HMFs in gelatin gels. Initially, it was determined that mTg was non-
toxic to the HMFs grown in 2D tissue culture plastic dishes.  This was important because 
the mTg would be used as the crosslinking agent for the 3D scaffold that would house the 
HMFs.  If the mTg were toxic to HMFs, this would pose an issue for creating the 
mechanically tuned hydrogels. In similar work, Ito et. al (2003) showed  that 
transglutaminase crosslinking of gelatin promoted fibroblast survival and proliferation.  
These results allowed for the use of mTg to be tested for its ability to effectively cross-
link the gelatin.  
Microbial transglutaminase has been shown to be an ideal crosslinking agent for 
creating hydrogels from thermally cooled gelatin (Yung, 2007). Here, gelatin hydrogels 
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were cross-linked with mTg and examined for changes in thermal stability. These tests 
were important in that the hydrogels would not maintain their solid, polymerized state in 
higher temperatures if mTg did not effectively cross-link the gelatin network. At 
500μg/mL, the highest mTg concentration, the gel weight decreased slightly. At 
6.3μg/mL, the lowest mTg concentration, the gels exhibited some swelling, but overall 
both concentrations yielded thermally stable gels. Thus, these results show that using too 
little mTg would cause the hydrogel to retain liquids, potentially a result of the limited 
number of cross-links in the matrix. Contrary, the greater amount of mTg in hydrogels 
showed a slight decrease in the gel weight, meaning that too much mTg may reduce 
liquid retention as a result of increased number of cross-links in the hydrogels.  
Since the gels were thermally stable, these data allowed for subsequent measurements of 
the bulk mechanical stiffness, which was performed using rheology.  
Pelham and Wang, for example, observed gels of varying stiffnesses (Wang, 1997). 
Rheological measurements of hydrogels cross-linked with different concentrations of 
mTg would enable the development of mechanically tuned hydrogels, which would serve 
as a basis for determining the influence of matrix stiffness on fibroblast responses. 
Therefore, the measure of stress/strain was recorded, where increased mTg 
concentrations yielded higher bulk mechanical stiffnesses, measured in Pascals. From 
these results, several concentrations were selected to serve as compliant 20μg/mL mTg 
(300 Pascals), moderately stiff, 30μg/mL mTg (1200 Pascals) and stiff, 60μg/mL mTg 
(1300 Pascals) hydrogels. Through work completed by Catlyn Thigpen, it was shown that 
the 60μg/mL mTg show yielded HMF proliferation that was significantly decreased in 
comparison to the compliant (20μg/mL) and moderately stiff (30μg/mL) gels. 
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To determine whether higher concentration of mTg yielded different responses, 75 
μg/mL (1800 Pacals) and 100 μg/mL mTg gels (1900 Pascals) were also tested on the 
cells. Results from these studies showed non-viable cells over a 7-day culture period; the 
environment was too stiff for the cells to remain alive for experimental procedures 
(procedures performed by Catlyn Thigpen). This information allowed for the compliant 
and stiff gels to be determined as 20μg/mL and 30μg/mL of mTG, respectively.  
Enzymatic stability was next evaluated. Collagenase was used to digest the gelatin in 
order to free the HMFs for further experiments. This experiment was used to gain the 
most efficient concentration of enzyme for the quickest digestion time. Three different 
concentrations were evaluated: 0.1mg/mL, 0.25mg/mL, and 0.5mg/mL. The 0.5mg/mL 
concentration had the shortest time for digesting gelatin cross-linked with 30µg/ml mTg. 
This permitted a better understanding of the concentration of collagenase needed for 
breakdown of the gelatin and thus, liberation of the encapsulated HMFs.  
Following analysis of gel physical properties following cross-linkage with mTg, 
HMFs were next encapsulated in 3D gelatin hydrogels cross-linked with concentrations 
of mTg yielding (20μg/mL) compliant and (30μg/mL) stiff gels. A cell culture system 
was created, whereby HMFs were in suspension with serum free DMEM, 20μg/mL or 
30μg/mL mTg, and gelatin. After gelation time, media was added to each gel for its 
culture period. This system served as the basis for the experimental work. After 
encapsulating HMFs in mTg cross-linked gels, HMF viability over the 7-day culture 
period was measured. Previous work by Bott et., al showed that fibroblasts encapsulated 
in a gelatin hydrogel covalently cross-linked, showed positive proliferation and viability 
outcomes (Bott, 2010). Similarly, it was shown that gelatin hydrogels cross-linked with 
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20μg/mL  (compliant) and 30μg/mL (stiff) mTg support HMF viability and growth 
during the 7-day culture period.   Specifically, the percent viability was measured in 
HMFs encapsulated in each of the gel conditions. Results showed that in both the 
compliant and stiff gels, the percent viable cells were significantly greater than the 
percent dead cells during the entire 7-day culture period. This shows that the 3D culture 
method for growing encapsulated HMFs is an optimal method of 3D cell culture. 
To determine whether ECM proteins are upregulated in HMFs exposed to a stiff 
as opposed to a compliant environment, conditioned media and cell lysate were 
examined. ECM protein expression patterns varied between HMFs encapsulated in 
compliant compared to stiff gels. Fibronectin had the highest expression overall in HMFs 
encapsulated in the compliant gels. This may be potentially explained by fibronectin’s 
action in breast tumor initiation, where it is possible the tumor itself may not be very stiff 
yet. For example, others have shown higher fibronectin expression in the beginning 
stages of breast cancer (Tomasek, 2002). Collagen I, a protein associated with breast 
tumor progression (Hinz, 2007), was found to be more highly expressed in HMFs 
encapsulated in stiff gels as opposed to compliant gels. Collagen I expression is highly 
correlated with stiffness in the breast tumor environment. Tenascin-C (Midwood, 2009) 
and collagen IV (Minz, 2010) are also highly expressed in breast cancer but in both 
compliant and stiff gels the expression level in HMFs was minimal for each gel 
condition. Laminin is a basement membrane protein of the ECM (Marangon, 2014). It is 
unclear why there was no laminin shown in the compliant or stiff gels. It is possible that 
due to the lack of basement membrane within the hydrogel, laminin was not seen in either 
the compliant or stiff gels.  
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Overall, the presence of the ECM proteins was observed, however not as much as 
expected in the stiff gels more specifically.  To determine whether there was as strong a 
presence of fibronectin (as seen in the compliant gels), immunofluorescence imaging was 
completed. Work from researchers like Paguirigan et. al (2006) showed the low 
autofluorescence of the structural components in the hydrogel would indicate that cellular 
proteins should be observed in 3D hydrogels using immunofluorescence. In a continued 
effort to observe ECM protein expression within the encapsulated HMFs in both 
compliant and stiff gels, immunofluorescence staining and imaging were completed. 
Staining was done only on fibronectin, because the expression was highly seen in the 
compliant gels from western blot results of protein lysate. Several techniques were 
employed in an attempt to increase the imaged expression of fibronectin. The first 
technique used to visualize fibronectin was to stain the gels in their original form of the 
well plate. This showed that though other staining, such as in Phalloidin and DAPI was 
very clear, the fibronectin staining was minimal. Therefore, it was attempted to make 
fibronectin staining better by sectioning the gel into fragments prior to staining. This 
caused damage to the cells, where they were squeezed and had an altered morphology. 
Also, there was still very little staining seen for fibronectin. Lastly, an attempt was made 
in fibronectin staining by decreasing the area of the gel space, by plating in a smaller well 
size, 96-well plate. The fibronectin staining was not evident. These procedures did not 
adequately detail the presence of fibronectin within 3D encapsulated HMFs.  However; 
there could be other techniques more successful in future experiments. Confocal 
microscopy is an optical imaging technique for increasing optical resolution and contrast. 
Also, paraffin embedding and sectioning, where thin slices are taken for more fine 
53  
staining quality, can potentially be used to view the presence of these various proteins 
within the gel.  
Conclusions 
Overall, the hypothesis was not fully proven, because ECM protein expression was not 
drastically different or much greater overall in the stiff gels in HMFs encapsulated than in 
compliant gels.. The ECM protein expression was not very conclusive in determining a 
strong difference of outcome between the compliant and stiff gel. Each gel type had a 
varied level of expression. However, several important features of the mTg gels and 
HMFs in mTG gels were revealed through the study. It has been shown that mTg 
effectively cross-links gelatin hydrogels and, at increasing concentrations, increases the 
mechanical stiffness of the gels. All in all, gelatin hydrogels cross-linked with 20µg 
(compliant) and 30µg (stiff) mTg support HMF viability and growth during the 7-day 
culture period. The general understanding for the study shows that HMFs are impacted by 
the varying environmental stiffnesses of compliant and stiff hydrogels that surrounds 
them during their culture when encapsulated in a 3D environment. 
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